Multicenter clinical experience with the afirma gene expression classifier

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages 119-125

  Alexander, Erik K ^a   Schorr, Melanie ^a   Klopper, Joshua ^e   Kim, Caroline ^b   Sipos, Jennifer ^c   Nabhan, Fadi ^c   Parker, Charles ^d   Steward, David L ^d   Mandel, Susan J ^b   Haugen, Bryan R ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFIRMA GENE EXPRESSION CLASSIFIER; ARTICLE; CANCER DIAGNOSIS; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CYTOLOGY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GENE EXPRESSION SYSTEM; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID NODULE; THYROID SURGERY; TREATMENT PLANNING; VALIDATION PROCESS;

BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NODULE; TRANSCRIPTOME;

EID: 84892161734     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2482     Document Type: Article

References (16)

1. Kim MI, Alexander EK. Diagnostic use of molecular markers in the evaluation of thyroid nodules. Endocr Pract. 2012;18:796-802.
2. Chudova D, Wilde JI, Wang ET, et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab. 2010;95:5296-5304.
3. Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96(11):3390-3397.
4. Cantara S, Capezzone M, Marchisotta S, et al. Impact of protooncolgene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab. 2010;95:1365.
5. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multisiciplinary approach to thyroid nodule diagnostic evaluation. Cancer Cytopathol. 2007;111(6):580.
6. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367:705-715.
7. Wang CC, Friedman L, Kennedy GC, et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011;21(3):243-251.
8. Duick DS, Klopper JP, Diggans JC, et al. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology. Thyroid. 2012;22(10): 996-1001.
9. Cibas ES, Ali SZ, NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132:658-665.
10. Kocjan G, Chandra A, Cross PA, et al. The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification system. Am J Clin Pathol. 2011; 135(6):852-859.
11. Gerhard R, da Cunha Santos G. Inter- and intraobserver reproducibility of thyroid fine needle aspiration cytology: an analysis of discrepant cases. Cytopathology. 2007;18(2):105-111.
12. Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008;130(5):736-744.
13. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-214.
14. Alexander EK. Approach to the patient with a cytologically indeterminate thyroid nodule. J Clin Endocrinol Metab. 2008;93:4175-4182.
15. Haymart MR, Banerjee M, Yang D, et al. Variation in the management of thyroid cancer. J Clin Endocrinol Metab. 2013;98:2001-2008.
16. Gharib H, Papini E, Paschke R, et al. American Association of Clinical Endocrinologists, Associazione Medicie Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest. 2010;33(suppl 5):51-56.